DefinitionThe rate of death from cancer of the prostate (ICD-10: C61) per 100,000 men.
NumeratorThe number of deaths due to prostate cancer for a given year (ICD-10: C61).
DenominatorThe male population in Utah or the U.S. for a given year.
Why Is This Important?Prostate cancer is the second most commonly occurring form of cancer for men, after skin cancer, and is the second leading cause of cancer death for men in Utah and the U.S.
Healthy People Objective C-7:Reduce the prostate cancer death rate
U.S. Target: 21.8 deaths per 100,000 males
Other ObjectivesCSTE Chronic Disease Indicators
How Are We Doing?In 2015, Utah's age-adjusted prostate cancer mortality rate was 17.4 per 100,000 males.
There was no significant difference in prostate cancer mortality among Utah's ethnic or racial groups, with the exception of Utah Asians having significantly lower rates than all races combined.
How Do We Compare With the U.S.?The U.S. prostate cancer age-adjusted mortality rate has been decreasing. Utah's prostate cancer age-adjusted mortality rate has varied from year-to-year and have closely mirrored national rate.[[br]][[br]]
In 2015, Utah's age-adjusted prostate cancer mortality rate was 17.4 per 100,000 males while the national rate was 18.8 per 100,000 males.
What Is Being Done?The Utah Department of Health initiated the Utah Cancer Action Network (UCAN), a statewide partnership whose goal is to reduce the burden of cancer. The mission of the UCAN is to lower cancer incidence and mortality in Utah through collaborative efforts directed toward cancer prevention and control. As a result of this planning process, objectives and strategies have been developed by community partners regarding the early detection of cervical, breast, and colorectal cancers as well as the promotion of physical activity, healthy eating habits, melanoma cancer prevention, and cancer survivorship advocacy.
Evidence-based PracticesScreening recommendations have changed over time.
Until recently, many doctors and professional organizations encouraged yearly PSA screening for men beginning at age 50.
However, as more has been learned about both the benefits and harms of prostate cancer screening, a number of organizations have begun to caution against routine population screening. Although some organizations continue to recommend PSA screening, there is widespread agreement that any man who is considering getting tested should first be informed in detail about the potential harms and benefits.
Since 2012 the U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer.
Healthy diet, exercise, and lifestyle play an important role in cancer prevention.